ADVANCED QUAD-PEPTIDE BLEND
Four Peptides, Four Pathways: The Most Complete Regenerative Formula
KLOW combines four powerful peptides — BPC-157, TB-500, KPV, and GHK-Cu — into a single advanced research formulation. This quad blend targets tissue repair, angiogenesis, inflammation control, and cellular regeneration through complementary mechanisms. By uniting these compounds, KLOW provides the most comprehensive platform for regenerative research available.
- Quad-peptide synergy: BPC-157 + TB-500 + KPV + GHK-Cu
- 80mg total peptide per vial (10mg + 10mg + 10mg + 50mg)
- Four distinct but complementary repair pathways
- Enhanced anti-inflammatory action with KPV addition
- Streamlined protocols vs. sourcing four separate compounds
For laboratory research use only. Not for human consumption.

QUAD-MECHANISM ACTION
How Four Peptides Create Synergistic Regeneration
Each peptide in KLOW targets a specific phase of the healing cascade. BPC-157 drives angiogenesis and growth factor signaling. TB-500 (full 43-amino-acid Thymosin Beta-4) promotes cell migration and cytoskeletal remodeling. KPV — the α-MSH(11-13) tripeptide — suppresses NF-κB activation and pro-inflammatory cytokines with potent antimicrobial effects. GHK-Cu stimulates collagen production and tissue remodeling at the genetic level.
- BPC-157: Angiogenesis, cytoprotection, gut lining repair
- TB-500: Actin regulation, cell migration, wound healing
- KPV: NF-κB suppression, antimicrobial, immune modulation
- GHK-Cu: Collagen synthesis, 4,000+ gene modulation
- Combined action across all stages of tissue repair
For laboratory research use only. Not for human consumption.

RESEARCH APPLICATIONS
From Inflammation Control to Multi-System Regeneration
KLOW’s unique quad-peptide design supports research across the broadest range of regenerative applications. The addition of KPV particularly enhances studies involving inflammatory conditions — from autoimmune research to gut barrier integrity. In murine colitis models, KPV treatment led to earlier recovery, significant weight regain, and reduced inflammatory infiltrates histologically.
- Inflammatory and autoimmune pathway research
- Gastrointestinal integrity and gut healing studies
- Tendon, ligament, and muscle repair modeling
- Wound healing and skin regeneration research
- Antimicrobial peptide activity investigations
- Comparative studies: quad vs. triple vs. single peptide
For laboratory research use only. Not for human consumption.

The Science Behind Quad-Peptide Synergy: Why KLOW Is the Ultimate Regenerative Platform
KLOW represents the most advanced peptide blend for regenerative research — combining four proven compounds into a single, synergistic formulation. While triple blends offer significant advantages over single peptides, KLOW takes this further by adding KPV’s powerful anti-inflammatory and antimicrobial properties.
The science behind each component is well-established. BPC-157 promotes angiogenesis, fibroblast activity, and gastrointestinal protection through growth factor signaling and FAK-paxillin activation. TB-500 (the full 43-amino-acid Thymosin Beta-4) regulates actin — a key protein for cell movement — enabling repair cell migration to injury sites. GHK-Cu modulates over 4,000 genes related to tissue growth, collagen production, and cellular repair.
The KPV addition is what sets KLOW apart. This C-terminal tripeptide (Lys-Pro-Val) derived from α-melanocyte-stimulating hormone reduces overactive immune signaling by suppressing NF-κB activation and pro-inflammatory cytokines. In two murine colitis models (DSS and CD45RBhi transfer), KPV treatment led to earlier recovery, significant weight regain, and reduced inflammatory infiltrates. It also demonstrates antimicrobial activity against S. aureus and C. albicans at physiological (picomolar) concentrations.
Together, these four peptides create an optimal healing environment: enhanced blood flow (BPC-157 + TB-500), controlled inflammation (KPV), and organized tissue remodeling (GHK-Cu). For research teams seeking the most comprehensive regenerative platform available, KLOW delivers four mechanisms in one streamlined formulation.
For research use only. Not for human consumption.
SCIENTIFIC REFERENCES (COMPONENT PEPTIDES)
- BPC-157: Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon. J Orthop Res. 2003;21(6):976-983.
- BPC-157: Gwyer D, et al. Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159.
- TB-500: Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368.
- TB-500: Bock-Marquette I, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-472.
- KPV: Cutuli M, et al. Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol. 2000;67(2):233-239.
- KPV: Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(3):324-331.
- KPV: Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178.
- GHK-Cu: Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987.


Reviews
There are no reviews yet.